Skip to Content

Newsletter No. 110 -- January 2009

NIH

Physical Science-Oncology Centers (U54) (NCI) (RFA-CA-09-009
Letter of intent receipt date: February 13, 2009
Application Receipt Date(s): March 13, 2009
Pre-application meeting: January 23, 2009
(see http://grants.nih.gov/grants/guide/notice-files/NOT-CA-09-010.html
The NCI solicits grant applications to build a collaborative Network of Physical Science-Oncology Centers (PSOCs). The goal is to collectively advance our understanding of the physical laws and principles that shape and govern the emergence of cancer and its behavior at all scales The PS-OCs will bring together expert teams from the fields of physics, cancer biology, physical chemistry, mathematics, and engineering to assemble and develop the infrastructure, capabilities, research programs, and network them to enable team research converging the physical sciences with cancer biology.
URL: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-09-009.html

National Cancer Institute Program Project (P01) Applications
(PAR-09-025)

Letter of intent submission dates: 1 month prior to applications receipt date.
Application Receipt/Submission Date(s): January 28, May 28, September 28
The NCI invites applications for investigator-initiated program project (P01) grants. Proposed program projects may address any of the broad areas of cancer research, including (but not limited to) cancer biology, cancer treatment, cancer diagnosis, cancer prevention, and cancer control.  Basic, translational, clinical, and/or population-based studies in all of these research areas are appropriate.  Each Program Project application must consist of at least three component projects.  The component projects must share a common central theme, focus, and/or overall objective.  Consult this notice and the other information while considering a P01.
URL: http://grants.nih.gov/grants/guide/pa-files/PAR-09-025.html

SHARED INSTRUMENTATION GRANT PROGRAM (S10)(NCRR)(PAR-09-028)
Application Receipt/Submission Date(s): March 23, 2009
The NCRR Shared Instrument Grant (SIG) program solicits applications from groups of NIH-supported investigators to purchase or upgrade commercially available instruments that cost at least $100,000.   The maximum award is $500,000.
URL: http://grants.nih.gov/grants/guide/pa-files/PAR-09-028.html

INSTRUMENT DEVELOPMENT FOR BIOMEDICAL APPLICATIONS (R21)(NCRR)(RFA-RR-09-001)
Application Receipt Date(s): January 27, 2009, September 30, 2009
The NCRR solicits innovative applications for the development of new or improved instrumentation for biomedical research. Projects should propose tools that can be used by a wide range of biomedical or clinical researchers, and not limited to a specific organ or disease.
URL: http://grants.nih.gov/grants/guide/rfa-files/RFA-RR-09-001.html

INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARD (U54) (ROADMAP) (RFA-RM-09-004)
Letters of Intent Receipt Date: September 14, 2009
Application Receipt Date(s): October 14, 2009
The Clinical and Translational Science Award (CTSA) initiative assists institutions to create an integrated academic home for Clinical and Translational Science that has the resources to train and advance multi- and inter-disciplinary investigators and research teams with access to innovative research tools and information technologies that apply new knowledge and techniques to patient care.
URL: http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-09-004.html

INNOVATION IN MOLECULAR IMAGING PROBES (R01)(MULTIPLE INSTITUTES)(PAR-09-016)
Letter of intent: 1 month prior to the application receipt date
Application Receipt Date(s): January 22, 2009; May 21, 2009; September 21, 2009; January 21, 2010; May 21, 2010; September 21, 2010; January 21, 2011; May 20, 2011; September 21, 2011
This FOA is issued by the NIBIB as a follow up of a previous Roadmap RFA (RM-04-021 "Innovation in Molecular Imaging Probes"). The purpose of this initiative is to encourage the development of novel molecular imaging approaches that can detect and image specific molecular activities in vivo, and have the potential for clinical applications. 
URL: http://grants.nih.gov/grants/guide/pa-files/PAR-09-016.html

OPTIMIZATION OF SMALL MOLECULE PROBES FOR THE NERVOUS SYSTEM (R21) (NINDS, NIAAA, NIDA) (RFA-NS-09-003)
Letters of Intent Receipt Date: February 3, 2009
Application Receipt Date(s): March 03, 2009
The NINDS, NIAAA, and NIDA wish to facilitate the discovery of new small molecule probes for investigating biological function in the nervous system by providing funding for advanced medicinal chemistry and the biological testing of small molecule probes as aids to hypothesis-driven research investigation, and as imaging agents.   
URL: http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-09-003.html

IMAGING-SCIENCE TRACK AWARD FOR RESEARCH TRANSITION (I/START) [R03] (NIDA) (PAR-09-073)
Application Receipt Date(s): Multiple dates, see announcement.
This funding opportunity announcement (FOA) encourages Small Research Grant (R03) applications to facilitate the entry of investigators to the area of neuroimaging, including both new investigators and established investigators seeking to adopt neuroimaging methodologies in their research programs.
URL: http://grants.nih.gov/grants/guide/pa-files/PAR-09-073.html

DEVELOPMENT OF BIOMARKERS FOR MENTAL HEALTH RESEARCH AND CLINICAL USE (NIMH, NCAAM) (SBIR [R43/R44]) (PA-09-045)
Application Receipt/Submission Date(s): Multiple dates, see announcement.
This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose the research and development of commercializable biomarker technologies relevant to mental disorders. The NIMH is specifically interested in clinically applied biomarkers as well as those useful in basic brain or behavioral research. Biomarkers could be noninvasively obtained (e.g., using optical or magnetic resonance imaging, etc.) or obtained with minimal invasiveness (e.g., using genetic, protein or metabolic signatures, physiological measures, etc.).
URL: http://grants.nih.gov/grants/guide/pa-files/PA-09-045.html

SELECTION OF APPROPRIATE FUNDING OPPORTUNITY ANNOUNCEMENTS (FOAS) FOR THE CONTINUATION OF THE INNOVATIVE MOLECULAR ANALYSIS TECHNOLOGIES (IMAT) PROGRAM FOR CANCER (NCI) (NOT-CA-09-007)
The NCI-sponsored Innovative Technologies for Molecular Analysis of Cancer (IMAT) Program, which is aimed at the development and integration of novel and emerging technologies in the support of cancer research, diagnosis, and treatment, now encompasses an array of 5 closely related Funding Opportunity Announcements (FOAs). This Notice is designed to help potential IMAT applicants identify appropriate FOAs.
URL: http://grants.nih.gov/grants/guide/notice-files/NOT-CA-09-007.html

REVISIONS TO RESEARCH OBJECTIVES in PA-08-267, Exploratory Studies in Cancer Detection, Diagnosis, and Prognosis (R21) (NCI) (NOT-CA-09-008)
URL: http://grants.nih.gov/grants/guide/notice-files/NOT-CA-09-008.html

PROBES FOR MICROIMAGING THE NERVOUS SYSTEM (MULTIPLE INSTITUTES) (SBIR [R43/R44]) (PA-09-062)
Application Receipt/Submission Date(s): Multiple dates, see announcement.
This FOA invites SBIR applications that propose research and development of probes that generate signals detectable by one or more imaging modality. Of special interest are applications that propose research and development of novel probes, although significant enhancements of already existing probes are also invited. Some examples of general research topics that would be considered appropriate to this FOA are listed: Research and development of probes that attach to specific sites on proteins which are observable through multiple modalities (e.g., magnetic resonance, optical); Research and development of caged molecules that provide temporally and spatially controlled release of molecular probes; Research facilitating collaborative research between the "probe" chemists (including radio, optical, and magnetic resonance chemists) and the biological or clinical investigators; Research and development of imaging probes through directed chemical modification of probe "leads" using biological screening employing previously developed in vitro assays, to determine structure-activity relationships; Research and development of specialized software/informatics for performing automated specificity analysis of imaging probes, to help streamline the process of sensitivity testing in vivo, especially for analysis involving multiple imaging modalities or multiple neurological and psychiatric disorders.
URL: http://grants.nih.gov/grants/guide/pa-files/PA-09-062.html

RESEARCH ON THE COGNITIVE SEQUELAE OF PARKINSONS DISEASE (MULTIPLE INSTITUTES) (R01: PA-09-033) (R21: PA-09-034)
Application Receipt/Submission Date(s): Multiple dates, see announcement.
The institutes involved invite research grant applications that address the underlying neurobiological mechanisms associated with cognitive impairment and mood disturbance in Parkinson's disease (PD), that address the development of clinical interventions and therapeutics for cognitive impairment and affective symptoms in PD, or that promote improved clinical diagnosis or treatment of cognitive and affective impairment in PD. Projects that employ neuroimaging and other biomarker approaches for these studies are encouraged. 
URL for R01: http://grants.nih.gov/grants/guide/pa-files/PA-09-033.html
URL for R21: http://grants.nih.gov/grants/guide/pa-files/PA-09-034.html

BRAIN IMAGING STUDIES OF NEGATIVE REINFORCEMENT IN HUMANS (NIDA) (R01: RFA-DA-09-008) (R21: RFA-DA-09-009)
Letters of Intent Receipt Date: January 19, 2009
Application Receipt Date: February 19, 2009
These FOAs solicit R01 and R21 applications from institutions/ organizations that propose to investigate brain processes in humans underlying how aversive events control behavior in order to stimulate a program of clinical neuroscience research on negative reinforcement / avoidance learning. 
URL for R01: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-09-008.html
URL for R21: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-09-009.html

CIP Announcements

CIP DCIDE PROGRAM
The Cancer Imaging Program of the NCIrequests submissions for its Development of Clinical Imaging Drugs and Enhancers (DCIDE) initiative. The goal is the rapid movement of promising, novel cancer imaging enhancers or molecular probes from the laboratory to proof-of-principle clinical trials. See the web site for details.
URL:http://imaging.cancer.gov/programsandresources/specializedinitiatives/dcide

GUEST AUTHOR OPPORTUNITIES IN THE NIH MICAD DATABASE
The Molecular Imaging and Contrast Agent Database (MICAD) program has been developed as a key component of the NIH Molecular Imaging Roadmap to provide freely accessible online scientific information on in vivo molecular imaging and contrast agents. To accelerate expansion of the database to include all published agents, the MICAD program has implemented a procedure for members of the imaging community to write and submit entries (chapters) as guest authors to the database. All members of the imaging community are encouraged to consider this guest author opportunities. For further information, please contact the MICAD staff at micad@ncbi.nlm.nih.gov. Individual guest authors will be provide with detailed instructions, style guidelines, and a chapter template. The name of the contributing author(s) will be acknowledged and included in the MICAD online publication.
URL: http://micad.nih.gov
URL: http://bookshelf.ncbi.nlm.nih.gov/books/bookres.fcgi/micad/infoguest.html)

Notices

NIBIB POLICY UPDATE FOR ACCEPTING PROGRAM PROJECTS (P01) AND TECHNOLOGY CORE CENTER(NOT-EB-08-005)
URL:http://grants.nih.gov/grants/guide/notice-files/NOT-EB-08-005.html

CLARIFICATION OF NOT-OD-08-014 AND NOT-OD-08-023 REGARDING REGISTRATION IN CLINICALTRIALS.GOV (NOT-OD-09-030)
URL: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-09-030.html
NIH TO MIGRATE APPROXIMATELY 100 FOAS IN EARLY DEC; APPLICANTS WILL RECEIVE AUTOMATED E-MAIL FROM GRANTS.GOV(NOT-OD-09-022)
National Institutes of Health, Agency for Healthcare Research and Quality, Food and Drug Administration, National Institute for Occupational Safety and Health
URL:http://grants.nih.gov/grants/guide/notice-files/NOT-OD-09-022.html

ENHANCING PEER REVIEW:
The NIH Announces Updated Implementation Timeline (NOT-OD-09-023)
URL for Timeline:http://grants.nih.gov/grants/guide/notice-files/NOT-OD-09-023.html
The NIH Announces New Scoring Procedures for Evaluation of Research Applications Received for Potential FY2010 Funding (NOT-OD-09-024)
URL for New Scoring Procedures:http://grants.nih.gov/grants/guide/notice-files/NOT-OD-09-024.html
The NIH Announces Enhanced Review Criteria for Evaluation of Research Applications Received for Potential FY2010 Funding <_28_not-od-09-02529_></_28_not-od-09-02529_>
URL for Enhanced Review Criteria: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-09-025.html
The NIH Center for Scientific Review Updates the Descriptions of its Chartered Review Panels (NOT-OD-09-027)
URL: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-09-027.html
Impact of NIH Transition to Adobe Forms on Appointed Members of NIH Chartered Study Sections (NOT-OD-09-028)
URL: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-09-028.html
REMINDER AND CLARIFICATION ON NIH/AHRQ/CDC/FDA TRANSITION to Adobe-based forms for SF424 Research and Related Electronic Submissions through Grants.gov
NIH is moving from PureEdge-based grant application forms to forms that use Adobe Reader software. Most electronic submissions to NIH on or after January 1, 2009 will require the use of the new Adobe-based forms.
URL: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-09-020.html

NIH ANNOUNCES THE AVAILABILITY OF ADOBE-BASED GRANT APPLICATION FORMS (NOT-OD-09-026)
URL:http://grants.nih.gov/grants/guide/notice-files/NOT-OD-09-026.html
RePORT (the Research Portfolio Online Tool
A new website, has been launched to give the public a single access point to quickly and easily find data, including information on NIH expenditures and the results of NIH-supported research. RCDC (Research, Condition, and Disease Categorization) results will show the amount NIH funded in each of the same 215 categories it has historically reported to Congress and the public. The results will be accessible through the RePORT website. Each category will provide detailed information, including for the first time a complete list of all NIH-funded projects included in that category.
URL: http://report.nih.gov

Meetings

SNM Mid-Winter Educational Symposium and Molecular Imaging Clinical Trials Network Community Workshop
February 5-8, 2009, Hilton Clearwater, Florida
URL: www.snm.org/mwm

SPIE Medical Imaging 2009
February 7-12, 2009, Disney Coronado Springs Resort, Lake Buena Vista (Orlando Area), Florida
URL: http://spie.org/medical-imaging.xml

4th Annual Symposium on PET/CT and Molecular Imaging
February 12-14, 2009, Bellagio Hotel, Las Vegas, NV
URL: http://radiologycme.stanford.edu/2009pet/

34th Annual Scientific Meeting, Society of Interventional Radiology
March 7-12, 2009, San Diego, CA
URL: http://www.sirweb.org/

In Vivo Small Animal Imaging Workshop>
March 23-25 2009, Center for Molecular and Genomic Imaging, University of California Davis, CA
URL: http://imaging.bme.ucdavis.edu/events.html

2009 NIH Regional Seminars on Program Funding and Grants Administration (NOT-OD-09-012)
The 2-day seminar provides information about the NIH funding process, from opportunity identification and application preparation through post award administration. Presentations will be targeted towards research administrators, new investigators, post docs and trainees. Opportunities for informal interactions between seminar participants and NIH grants management, program, policy, and review staff are incorporated into the program. NIH electronic research administration (eRA) computer workshops are offered on a day adjacent to the two day seminar.
April 16-17, 2009 - Atlanta, Georgia.
URL: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-09-012.html

>17th Scientific Meeting and Exhibition, International Society for Magnetic Resonance in Medicine (ISMRM)
April 18-24, 2009, Honolulu, Hawaii
URL: http://www.ismrm.org/09/

SIIM 2009 Society for Imaging Informatics in Medicine
June 4-7, 2009, Charlotte, NC
URL: http://www.scarnet.org/index.cfm?id=4324

56th Annual Society of Nuclear Medicine Meeting
June 13-17, 2009, Toronto, Ontario Canada
URL: http://interactive.snm.org/index.cfm?PageID=7878&RPID=1977

2009 NIH Regional Seminars on Program Funding and Grants Administration (NOT-OD-09-012)
The 2-day seminar provides information about the NIH funding process, from opportunity identification and application preparation through post award administration. Presentations will be targeted towards research administrators, new investigators, post docs and trainees. Opportunities for informal interactions between seminar participants and NIH grants management, program, policy, and review staff are incorporated into the program. NIH electronic research administration (eRA) computer workshops are offered on a day adjacent to the two day seminar.
June 25-26, 2009 - Las Vegas, Nevada.
URL: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-09-012.html

18th International Symposium on Radiopharmaceutical Sciences
July 12-17, 2009, Edmonton, Alberta Canada
URL: http://www.isrs18.com/

Imaging in 2020
September 13-17, 2009, Wyoming
URL: http://www.imagingin2020.com/

World Molecular Imaging Congress
September 23 - 26, 2009,Montreal, Quebec Canada
URL: http://www.wmicmeeting.org/dev/


If you wish to remain on the list, no action is necessary. If you wish to be added to the list, please contact Dr Barbara Croft by return e-mail (bc129b@nih.gov). Please include your complete mailing address, title, phone and fax numbers.

Cancer Imaging Program,
Division of Cancer Treatment and Diagnosis,
NCI 6130 Executive Boulevard - MSC-7412
Bethesda, MD 20892-7412
Tel: 301 496 9531
Fax: 301 480 3507